Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets
Clinical trial NCT02106923 · COMPLETED
Trial details
- NCT number
- NCT02106923
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-06-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.